680
Participants
Start Date
March 31, 2016
Primary Completion Date
January 31, 2020
Study Completion Date
November 17, 2022
ONO-4538
Oxaliplatin
Tegafur- Gimeracil-Oteracil potassium
Capecitabine
Placebo
Aichi Clinical Site, Nagoya
Aomori Clinical Site, Hirosaki
Aomori Clinical Site, Misawa
Chiba Clinical Site, Funabashi
Chiba Clinical Site, Kamogawa
Chiba Clinical Site, Kashiwa
Ehime Clinical Site1, Matsuyama
Ehime Clinical Site2, Matsuyama
Fukuoka Clinical Site, Iizuka
Fukuoka Clinical Site1, Kitakyushu
Fukuoka Clinical Site2, Kitakyushu
Fukuoka Clinical Site, Kurume
Gifu Clinical Site, Gifu
Gifu Clinical Site, Ōgaki
Gumma Clinical Site, Maebashi
Gunma Clinical Site, Ōta
Gumma Clinical Site, Takasaki
Hiroshima Clinical Site, Kure
Hokkaido Clinical Site, Hakodate
Hokkaido Clinical Site1, Sapporo
Hokkaido Clinical Site2, Sapporo
Hokkaido Clinical Site3, Sapporo
Hokkaido Clinical Site4, Sapporo
Hyogo Clinical Site, Akashi
Hyogo Clinical Site, Amagasaki
Hyogo Clinical Site, Kobe
Hyogo Clinical Site, Nishinomiya
Ibaraki Clinical Site, Higashiibaraki-gun
Ibaraki Clinical Site, Tsuchiura-shi
Ishikawa Clinical Site1, Kanazawa
Ishikawa Clinical Site2, Kanazawa
Iwate Clinical Site, Morioka
Kagawa Clinical Site, Kita-gun
Kanagawa Clinical Site, Isehara
Kanagawa Clinical Site, Kamakura
Kanagawa Clinical Site, Sagamihara
Kanagawa Clinical Site1, Yokohama
Kanagawa Clinical Site2, Yokohama
Kanagawa Clinical Site3, Yokohama
Miyagi Clinical Site, Natori-shi
Miyagi Clinical Site, Ōsaki
Miyagi Clinical Site, Sendai
Nagano Clinical Site, Saku
Nara Clinical Site, Ikoma
Nara Clinical Site, Kashihara-shi
Okayama Clinical Site, Kurashiki
Osaka Clinical Site, Izumi
Osaka Clinical Site, Sakai
Osaka Clinical Site, Sayama
Osaka Clinical Site, Suita
Osaka Clinical Site, Takatsuki
Osaka Clinical Site, Toyonaka
Saitama Clinical Site, Hidaka
Saitama Clinical Site, Kitaadachi-gun
Shizuoka Clinical Site, Hamamatsu
Tochigi Clinical Site, Shimotsuke
Tochigi Clinical Site, Utsunomiya
Tokyo Clinical Site, Bunkyo-ku
Tokyo Clinical Site, Chuo-ku
Tokyo Clinical Site, Fuchū
Tokyo Clinical Site, Koto-ku
Tokyo Clinical Site, Minato-ku
Tokyo Clinical Site, Shinagawa-ku
Tokyo Clinical Site1, Shinjuku-ku
Tokyo Clinical Site2, Shinjuku-ku
Tokyo Clinical Site, Tachikawa
Tottori Clinical Site, Yonago
Yamagata Clinical Site, Sakata
Akita Clinical Site, Akita
Chiba Clinical Site1, Chiba
Chiba Clinical Site2, Chiba
Fukui Clinical Site, Fukui
Fukuoka Clinical Site1, Fukuoka
Fukuoka Clinical Site2, Fukuoka
Fukuoka Clinical Site3, Fukuoka
Fukuoka Clinical Site4, Fukuoka
Fukushima Clinical Site, Fukushima
Hiroshima Clinical Site1, Hiroshima
Hiroshima Clinical Site2, Hiroshima
Hiroshima Clinical Site3, Hiroshima
Kumamoto Clinical Site1, Kumamoto
Kumamoto Clinical Site2, Kumamoto
Kumamoto Clinical Site3, Kumamoto
Kyoto Clinical Site1, Kyoto
Kyoto Clinical Site2, Kyoto
Kyoto Clinical Site3, Kyoto
Niigata Clinical Site, Niigata
Okayama Clinical Site, Okayama
Osaka Clinical Site1, Osaka
Osaka Clinical Site2, Osaka
Osaka Clinical Site3, Osaka
Osaka Clinical Site4, Osaka
Shizuoka Clinical Site, Shizuoka
Tokushima Clinical Site, Tokushima
Toyama Clinical Site, Toyama
Wakayama Clinical Site, Wakayama
Yamagata Clinical Site, Yamagata
Gyeongnam Clinical Site, Gyeongnam
Busan Clinical Site, Busan
Daegu Clinical Site 1, Daegu
Daegu Clinical Site 2, Daegu
Daejeon Clinical Site, Daejeon
Gyeonggi-Do Clinical Site1, Gyeonggi-do
Gyeonggi-Do Clinical Site2, Gyeonggi-do
Gyeonggi-Do Clinical Site3, Gyeonggi-do
Gyeonggi-Do Clinical Site4, Gyeonggi-do
Gyeonggi-Do Clinical Site5, Gyeonggi-do
Incheon Clinical Site, Incheon
Jeollabuk-Do Clinical Site, Jeollabuk-Do
Jeollanam-do Clinical Site, Jeollanam-do
Seoul Clinical Site 1, Seoul
Seoul Clinical Site 2, Seoul
Seoul Clinical Site 3, Seoul
Seoul Clinical Site 4, Seoul
Seoul Clinical Site 5, Seoul
Seoul Clinical Site 6, Seoul
Seoul Clinical Site7, Seoul
Seoul Clinical Site8, Seoul
Seoul Clinical Site9, Seoul
Ulsan Clinical Site, Ulsan
Kaohsiung Clinical Site1, Kaohsiung City
Kaohsiung Clinical Site2, Kaohsiung City
New Taipei Clinical Site 1, New Taipei City
Taichung Clinical Site 1, Taichung
Taichung Clinical Site2, Taichung
Tainan Clinical Site1, Tainan City
Tainan Clinical Site2, Tainan City
Taipei Clinical Site1, Taipei
Taipei Clinical Site2, Taipei
Taoyuan Clinical Site, Taoyuan District
Lead Sponsor
Ono Pharmaceutical Co. Ltd
INDUSTRY